Alteration in pulmonary surfactant associated with cardiopulmonary bypass. Further observations and conclusions.
D000293:Adolescent; D000328:Adult; D001344:Autopsy; D002648:Child; D005112:Extracorporeal Circulation / Q000009:adverse effects*; D006331:Heart Diseases / Q000601:surgery*; D006343:Heart Septal Defects / Q000503:physiopathology; D006349:Heart Valve Diseases / Q000503:physiopathology / Q000601:surgery; D006439:Hemodynamics; D006801:Humans; D008074:Lipoproteins; D008168:Lung / Q000473:pathology / Q000502:physiology / Q000503:physiopathology*; D013499:Surface Properties; D013501:Surface-Active Agents; D013771:Tetralogy of Fallot / Q000503:physiopathology; D013997:Time Factors
D008074:Lipoproteins; D013501:Surface-Active Agents